scispace - formally typeset
P

Pierre Larochelle

Researcher at Université de Montréal

Publications -  127
Citations -  7331

Pierre Larochelle is an academic researcher from Université de Montréal. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 41, co-authored 127 publications receiving 7112 citations. Previous affiliations of Pierre Larochelle include Hotel Dieu Hospital.

Papers
More filters
Journal ArticleDOI

Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons

TL;DR: Increased cost-sharing for prescription drugs in elderly persons and welfare recipients was followed by reductions in use of essential drugs and a higher rate of serious adverse events and ED visits associated with these reductions.
Journal ArticleDOI

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Kaberi Dasgupta, +68 more
TL;DR: The Canadian Hypertension Education Program reviews the hypertension literature annually and provides detailed recommendations regarding hypertension diagnosis, assessment, prevention, and treatment, and 4 new recommendations were added and 2 existing recommendations were modified this year.
Journal ArticleDOI

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension

Alexander A. Leung, +77 more
TL;DR: In the diagnosis and assessment of hypertension, automated office blood pressure, taken without patient-health provider interaction, is now recommended as the preferred method of measuring in-office blood pressure as mentioned in this paper.
Journal ArticleDOI

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

TL;DR: The evidence-based recommendations for the prevention and treatment of hypertension in adults for 2010 are updated and treatment thresholds and targets should be predicated on the patient's global atherosclerotic risk, target organ damage and comorbid conditions.
Journal ArticleDOI

Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.

TL;DR: Depressed active media stress responses to norepinephrine, arginine vasopressin, and endothelin-1 were accordingly normalized in the patients receiving cilazapril as the media width became thinner but were unchanged in those taking atenolol.